Pharmaceuticals, Biotechnology and Life Sciences
NANTES, France, October 17, 6:00pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting…
KEY FIGURES Revenue at the end of September €1 042.1M Growth at constant exchange rates and scope1 +8.6%…
BALTIMORE, Oct. 17, 2024 (GLOBE NEWSWIRE) — Rapafusyn Pharmaceuticals, a leader in the field of non-degrading molecular glues, is pleased…
— LUMRYZ is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness (EDS) in patients 7 years…
Total eligible patients in the US exceed 2 million.Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active…
FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today…
SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted…
-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone paymentsTHE WOODLANDS,…
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with managementGERMANTOWN, Md., Oct.…
WARREN, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage…